Health
Merck, IFFS Tackle Infertility In Africa
By Modupe Gbadeyanka
Leading science and technology company, Merck, through its ‘Merck More than a Mother’, has conducted a high level panel to addressed infertility challenges in Africa, with a view to finding solutions to them.
The panel was set in partnership with the International Federation of Fertility Societies (IFFS) at the opening ceremony of the World Congress of (IFFS) held in New Delhi, India.
The high level panel of ministers, parliamentarians and global fertility experts from IFFS and Africa Fertility Society highlighted lack of access to regulated fertility care and awareness about infertility management and widespread stigma of infertile women as some of the key challenges in Africa.
The panel called for increased efforts to improve access to regulated fertility care through the development of artificial reproductive therapy (ART) laws and regulations and to empower infertile women through access to education and information. They also supported the training of African embryologists and discussed different interventions to remove the infertility stigma and create a culture shift and change of mind set.
The high level panel including Sarah Opendi, Minister of Health, Uganda; Betty Amongi, Uganda’s Minister of Lands, Housing and Urban Development and Chair of Uganda Women Parliamentarian Association; Julia Duncan-Cassell, Minister of Gender, Liberia; Joyce Lay, Member of Parliament, Kenya; Dr Patrick Amoth, Senior Deputy Director of Medical Services, Ministry of Health, Kenya; Prof. Joe Leigh Simpson, Former President of International Federation of Fertility Societies (IFFS); Prof. Richard Kennedy, President of IFFS; Prof. Oladapo Ashiru, President of Africa Fertility Society; Dr. James Olobo-Lalobo, Vice-President of Africa Fertility Society, Uganda and Dr. Rasha Kelej, Chief Social Officer, Merck Healthcare supported the implementation of ‘Merck More than a Mother’s’ strategic objectives and interventions across Africa.
“The aim of ‘Merck More than a Mother’ is to empower infertile women in Africa through improving access to education, information and health and change of mind-set and in case they cannot be treated the campaign is empowering them economically and socially through ‘Empowering Berna’ Project so that they can be independent and re-build their own lives,” said Dr. Rasha Kelej, Chief Social Officer, Merck Healthcare.
“In Uganda, between 15-20% of couples fail to conceive. The number of fertility clinics in the country to address this problem are few and expensive. Together with ‘Merck More than a Mother’ in Uganda we are creating awareness that infertility can be prevented and that to improve access, fertility care can be integrated into the already existing public reproductive healthcare services which will be cost effective as the infrastructure is already there. In addition we are building a hospital for Women Health where we will dedicate an IVF center to provide couples with affordable and effective treatment with the support of Merck to train the future staff,” said Sarah Opendi, the Minister of Health, Uganda.
“In our culture, a woman is always blamed for infertility. She carry’s the shame, embarrassment and tears in private. We need to create awareness by providing information and education on infertility so that both men and women can talk about it. ‘Merck More than a Mother’ campaign has opened discussions on infertility and is talking about solutions and interventions available,” said Joyce Lay, Member of Parliament, Kenya.
At the meeting Merck showed a few videos of African infertile women who shared their stories of suffering due to failing to have children and their transformation after meeting Merck more than a Mother team who helped empower them socially and economically.
Speaking on the need to create a culture shift, Julia Duncan Cassell, Minister of Gender, Liberia said: “We should look at a woman as more than a mother. It is not always the fault of the woman when there is no child, but in our culture it is. We need to speak out as both men and women can be affected by infertility. Violence and stigma against infertile women should not be tolerated. We need to change our culture, tradition, attitude and mind-set. These can be modified and changed. We hope the ‘Merck More than a Mother’ initiative can be extended to other African countries so that awareness can increase and know that infertility can be caused by many factors and that with the right information it can be prevented.”
“In the African culture, marriage gives a woman the right to property and land. When they don’t bear children they are disinherited and when they go back home there is also nothing for them. Therefore, empowering infertile women economically and socially as ‘Merck More than a Mother’ is doing is important because most of them have nowhere to go. This enables them to sustain themselves and with the information they are given they become change agents in their communities,” said Betty Amongi, Minister of Lands, Housing and Urban Development, Uganda.
Prof. Joe Leigh Simpson, President of IFFS supported the need and importance of building fertility care capacity in Africa. “We in high resource countries have an obligation to provide education, service and translate in the shortest period of time the advances that are being made in our labs to middle and low resource countries”.
“IFFS has an important role to support ‘Merck More than a Mother’. We agree that education is essential and that we will support the education and training initiatives necessary in Africa to develop capacity for infertility treatment,” said Prof. Richard Kennedy, President elect of IFFS.
“In Nigeria people who come into our clinics are afraid because they don’t want people to know they are taking fertility treatment. In most of these cases only women seek treatment for infertility and not the men. People prefer to seek help elsewhere and by the time they come for medical help it is too late. We are happy that ‘Merck More than a Mother’ campaign is being launched in Nigeria and in Africa to create a culture shift that will enable people to seek proper treatment for infertility and that there is respect for womanhood than motherhood,” emphasized Prof. Oladapo Ashiru, President Africa Fertility Society.
Dr. Patrick Amoth, Senior Deputy Director of Medical Services, Ministry of Health Kenya pledged support for the work that ‘Merck More than a Mother’ is doing in Kenya. “The Ministry will play a key role in developing policy and guidelines to implement the ART law to ensure standards and regulations are maintained to protect couples seeking fertility treatment from exploitation,” he emphasized.
By Modupe Gbadeyanka
An organisation known as GoMed Nigeria is offering free reproductive health services to Nigerian students through a digital self-care platform.
This is being delivered through a partnership with the United Nations Population Fund (UNFPA) and the Lagos State Government.
The pilot scheme will be available to students of the University of Lagos. They will enjoy easier and more private access to essential health products, accurate information, and professional support.
Young Nigerians face some of the highest rates of unintended pregnancy and unmet need for contraception in the world.
Cost, distance, stigma, misinformation, and fears about confidentiality routinely stop students from seeking the products and guidance they need, with consequences that include unintended pregnancy, unsafe abortion, sexually transmitted infections and interrupted education.
The self-care platform is designed to remove each of these barriers. Through the platform, students receive free contraceptives and other sexual and reproductive health commodities provided through the Lagos State Ministry of Health and UNFPA, exclusive discounts on health essentials, and fast, discreet delivery directly to campus and student hostels.
Students can also access trusted sexual and reproductive health information and services through UNFPA’s SoftLife 247 and U-Plan platforms. Through U-PLAN, they can chat directly with qualified Family Planning Service Providers to receive accurate information and address their concerns. They can also confidently engage with GoMed’s registered pharmacists for confidential, judgement-free guidance on medicines and other health products.
“Students should be able to get reliable health information and essential products without cost, distance or fear of judgement becoming barriers.
“This platform brings free sexual and reproductive health commodities, other affordable health products and professional guidance together, with discreet delivery directly to students on campus,” the chief executive of GoMed Nigeria, Mr Anthony Edeki, said.
Also speaking, UNFPA in Nigeria Resident Representative, Muriel Mafico, said, “As the UN agency mandated for “Sexual and Reproductive Health and Rights”, we are committed to reducing preventable maternal deaths and addressing the unmet need for family planning, including by providing and overseeing access to life-saving commodities worldwide.
“Working alongside our partners, we’re helping roll out the digital Self-Care Platform—so that vital, life-changing information can reach more people, more easily. Together, we want to empower Nigeria’s next generation to make informed health choices and achieve stronger health outcomes and a brighter future.”
By Modupe Gbadeyanka
A financing framework to accelerate the electrification of health facilities nationwide has been approved by the federal government.
The approval was announced at the third meeting of the Inter-Ministerial Steering Committee (IMSC) of the Nigeria Power for Health Initiative (NPHI), a presidential programme jointly coordinated by the Federal Ministries of Power and Health and Social Welfare.
The committee was constituted to ensure reliable electricity in at least 30 per cent of Nigeria’s health facilities by the end of 2027.
At the meeting, chaired by the Minister of State for Health and Social Welfare, Mr Isiaq Salako, and co-chaired by the Minister of Power, Mr Joseph Tegbe, members of the Inter-Agency Technical Committee (IATC) presented the recommendations under consideration.
Speaking at the meeting, Mr Salako said the Steering Committee approved a financing framework to mobilise investment for healthcare electrification, alongside a facility energy management framework requiring participating hospitals to build sustainable systems for managing their energy infrastructure.
He said the committee also cleared eight (8) private sector proposals for further engagement, drawn from about 70 submissions received during the National Healthcare Electrification Investor Matchmaking Week in Lagos.
The Health Minister added that Energy Management Teams are already in place at federal tertiary hospitals, with state governments being encouraged to set up similar structures. The initiative will now be institutionalised through dedicated budgetary provisions and a full-time Project Coordination Unit to oversee implementation.
On his part, Mr Tegbe declared that the initiative must now move from announcements to actual project delivery.
Describing the NPHI as one of the President Bola Tinubu administration’s flagship programmes, he said the emphasis should shift towards commissioning completed projects that Nigerians can see for themselves, rather than further groundbreaking ceremonies and public messaging.
He emphasised the need for teaching hospitals, state hospitals, and primary healthcare centres to be fully energised, noting that the Rural Electrification Agency has already energised 5 Federal Teaching Hospitals and several other health facilities nationwide.
He also tied the initiative directly to patient outcomes, arguing that dependable power would end hospitals’ reliance on emergency generators, and pledged that the Ministry would continue to prioritise the initiative’s funding needs while ensuring value for money.
By Kestér Kenn Klomegâh
Health authorities in the Democratic Republic of Congo (DRC) and the Africa Centres for Disease Control and Prevention (Africa CDC) have bitterly complained over their inability to track down new cases of Ebola, which has spread into the Republic of Uganda. An estimated 1,635 Ebola cases have been confirmed, and 127 people have died from the dangerous infectious disease in the DRC.
The Ebola outbreak is increasingly impacting social interaction and people-to-people movements, as scepticism toward the disease appears to accelerate among the population, and cross-border movements are being controlled daily. Alarm was sounded last week as the virus moved into new areas of the DRC. In some instances, patient routinely escapes, and limited contact tracing undermines containment efforts. Contact tracing coverage has plummeted to 56.5 per cent, a sharp decline from the 95 per cent target, Health Ministry officials said.
“We remain committed to supporting affected countries until transmission is stopped. We call on partners and donors to urgently mobilise resources to strengthen the response and save lives,” Jean Kaseya, director general of the Africa Centres for Disease Control and Prevention, said on Sunday.
Shortage of Medical Kits
The World Health Organisation (WHO) reported that the three major laboratories, in South and North Kivu, have run out of Ebola testing kits, as infections continue to rise daily. Teams are working through a large backlog of samples from suspected Ebola patients, many of which were collected several weeks ago, to confirm or rule out the presence of the deadly virus.
In a situation report released earlier this week, the global health agency said the labs in major cities including Bukavu and Goma were awaiting the arrival of reagents–substances ​ required to run the tests–to resume work on the backlog of samples.
“Running out of Ebola testing reagents during an active outbreak is a serious setback,” Dr Krutika Kuppalli, associate professor in the division of infectious diseases at the University of Texas Southwestern and former WHO officer, told The Telegraph.
“Diagnostics are the foundation of outbreak control; if cases cannot be rapidly confirmed, this may lead to delays in isolation, treatment, and contact tracing, which can allow transmission to continue unchecked,” said Dr Kuppalli.
The Race for Vaccines
Vaccine candidates are racing to fill the gap. The Coalition for Epidemic Preparedness Innovations (CEPI)—a multinational nonprofit organisation that finances vaccine development for emerging infectious diseases—has so far prioritised several vaccine candidates for development.
Two are Ervebo-like prototypes aimed at recognising Bundibugyo’s specific blend of glycoproteins, a platform that showed experimental potential years ago. In 2013, an early version of the vaccine protected 100 per cent of monkeys infected with Bundibugyo. However, because most Ebola outbreaks didn’t involve this species, the vaccine didn’t get the investment needed to become licensed. That’s an outcome CEPI aims to remedy with its latest investment.
The International AIDS Vaccine Initiative and Public Health Vaccines are developing the vaccines, which, like Ervebo, also rely on the vesicular stomatitis virus. WHO called this technology the most promising of the candidates.
VSV-based vaccines are front-runners because the weakened version of the virus used to produce them is so good at replicating itself inside humans—including the small chunk of whatever germ it’s been hybridised with—without causing harm. As a result, a single dose typically leads to a strong immune response.
Another candidate, called ChAdOx1, operates using a similar concept: A virus shows the immune system part of a pathogen to generate a protective response. However, it uses an adenovirus that causes colds in chimpanzees—and is also harmless to humans—that University of Oxford scientists modified to keep it from replicating.
There’s also a vaccine candidate based on Moderna’s mRNA science, which was also used to produce the company’s COVID-19 vaccines. This vaccine employs tiny fat bubbles to deliver genetic instructions to cells on how to produce a small part of the Bundibugyo virus. The immune system generates a protective response, and the mRNA degrades quickly without causing lasting changes to cells’ genetic codes.
US-Backed Kenya’s Quarantine Centre
Health Cabinet Secretary Aden Duale has consistently defended the establishment of US-backed health centres in Kenya. The US says it will quarantine citizens exposed to the virus but not showing symptoms in a facility it is building in Kenya, and will not bring them home if they develop symptoms, instead sending them to a third country.
The CDC imposed temporary travel bans last month on people who have been in the DRC, Uganda, or South Sudan, including green card holders, who are typically exempt from such bans. It is also screening Americans travelling from those countries at three US airports. The strategy marks a sharp break from past practice as President Donald Trump’s administration seeks to keep all cases out of US territory.
There are 13 US treatment centres in a government-funded hospital network for severe infectious diseases ready to handle Ebola patients. Public health experts have, however, called on the government to bring any sick Americans home for treatment, and local protests at the Kenya site have led to at least two deaths. A Kenyan court has ordered a halt to the construction.
WHO Appeals for International Community Support
In a rapid and comprehensive response to WHO’s appeal to marshal resources for support of Ebola prevention, the United States has provided an additional $38 million. The additional funds brought the total amount committed by the U.S. to more than $200 million in direct funding, the State Department said in an official statement.
CDC model scenarios show that without strong public health interventions, the outbreak of the Bundibugyo strain of Ebola in the DRC could become as large as, or even larger than, the 2014-2016 West Africa outbreak, the agency said.
In modelled scenarios where the isolation of patients is limited, the outbreak could become one of the largest ever documented, said Jason Asher, director of the CDC’s Centre for Forecasting and Outbreak Analytics.
From Addis Ababa, the Africa Centres for Disease Control and Prevention (Africa CDC) also said it had received a €11.5 million renewed commitment from the European Union Commission (EU) to support a stronger preparedness and coordinated response to the Ebola outbreak. Dr Jean Kaseya, Director General, Africa CDC, described the partnership with the European Union as respectful and without any conditionality, a type of partnership the continent needs.
The package is aimed at reinforcing the EU Commission’s support through the Africa CDC emergency response to the Ebola crisis, within the long-standing and comprehensive AU-EU health partnership. This demonstrates the central role of Africa CDC in coordinating the continental response to health emergencies, as well as the EU’s action as the world’s largest humanitarian contributor.
This includes €6.5 million to strengthen the Africa Pathogen Genomics Initiative, to help equip frontline teams, train healthcare workers and improve surveillance through diagnostics and an in-kind contribution of €5 million worth of testing equipment, including rapid diagnostic devices and lab test kits, to be deployed quickly where they are needed most. The EU’s partnership with Africa CDC spanning technical expertise, capacity-building, and policy dialogue continues to play a key role in building resilient health systems.
Ebola epidemic at G7 summit
Amid the horror of the Ebola epidemic, world leaders gathered at the G7 summit in France were urged to find the “political will” to push through the final part of the Pandemic Agreement on Monday. In a joint letter, Brazil’s President Luiz Lula da Silva and WHO chief Dr Tedros Adhanom Ghebreyesus urged leaders gathered on the shores of Lake Geneva to get the “benefits sharing” annex of the deal signed with a “sense of urgency.”
The Pandemic Agreement, which seeks to ensure the world is better prepared for the next global outbreak, was agreed last year but a vital element of it was deferred because of arguments over its wording. It is unclear, and perhaps unlikely, that a truly global agreement on benefits sharing can be reached.
Nevertheless, an agreement between the remaining 192 member states of the WHO is possible and would represent a major step forward. “Every month this annex stays unfinished is a month the world is less ready than it could be, and people are less safe than they deserve to be,” say Mr Lula da Silva and Dr Tedros. “Finalising this Agreement, through a shared commitment to one another, is our collective promise to protect humanity.”
The epidemic, caused by the rare Bundibugyo strain of the virus, for which there is no approved vaccine or specific treatment, was declared on May 15. It has since spread across Ituri, North Kivu and South Kivu, regions marked by insecurity, displacement and cross-border movement.
The Democratic Republic of the Congo (DRC), also known as the DR Congo, is situated in the central African region. With a population of around 124 million people, it shares borders with the Republic of Congo and Angola to the south, the Atlantic Ocean, and the Central African Republic and South Sudan to the north, and also with Uganda, Rwanda, Burundi, and Tanzania (across Lake Tanganyika) to the east, and Zambia and Angola to the south.
